Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated informed consent.~* Male or female aged ≥ 18 years old.~* Diagnosis of moderate to severe dry eye syndrome~Exclusion Criteria:~* Pregnancy, lactation.~* Childbearing potential woman who is not using a reliable method of contraception and is not surgically sterilised.~* Inability of patient to understand the study procedures and thus inability to give informed consent.~* Non-compliant patient~* Participation in another clinical study at the same time as the present study.~* Participation to the present study during the exclusion period of another clinical study.~* Already included once in this study.~* Ward of court.~* Patient not covered by government health care scheme

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- T2762 (Type: EXPERIMENTAL): One drop of T2762 in each eye 3 to 6 times daily
- Optive (Type: ACTIVE_COMPARATOR): One drop of Optive in each eye 3 to 6 times daily

Based on this trial design, predict the completion outcome and termination type (if applicable).